Steuber Thomas相关文献与解析，生知库 | 链接生命科学的每一步

Kniep, Christopher; Maurer, Tobias; Hartwieg, Ben Frederik; Mandel, Philipp; Wenzel, Mike; Falkenbach, Fabian; Krpina, Kristian; Budäus, Lars; Haese, Alexander; Salomon, Georg; Steuber, Thomas; Graefen, Markus; Tilki, Derya; Preisser, Felix

肿瘤

前列腺癌

肿瘤免疫

发表日期：2026

文献求助收藏

Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort

接受阿帕鲁胺治疗的转移性激素敏感性前列腺癌且骨转移灶≥10个的患者的癌症控制结果：一项真实世界队列研究

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-026-15803-y

Wenzel, Mike; Filzmayer, Maximilian; Siech, Carolin; Le, Quynh Chi; Lauer, Benedikt; Theissen, Lena; Hoeh, Benedikt; Heinzer, Hans; Graefen, Markus; Steuber, Thomas; Kriegmair, Maximilian; Chun, Felix K-H; Mandel, Philipp

Influence of concomitant distant lymph node metastases in metastatic hormone-sensitive prostate cancer patients with bone metastases

伴随远处淋巴结转移对骨转移性激素敏感性前列腺癌患者的影响

期刊:World Journal of Urology

影响因子:2.9

doi:10.1007/s00345-026-06358-5

Wenzel, Mike; Lauer, Benedikt; Mühlthaler, Vincenzo Giuseppe; Filzmayer, Maximilian; Siech, Carolin; Le, Chi; Humke, Clara; Kosiba, Marina; Kriegmair, Maximilian; Steuber, Thomas; Chun, Felix K H; Mandel, Philipp

External Validation of the Martini-Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High-Risk Prostate Cancer After Radical Prostatectomy

根据欧洲泌尿外科协会（EAU）指南，对接受根治性前列腺切除术的高危前列腺癌患者进行Martini-Klinik列线图预测辅助放射治疗适应症的外部验证

期刊:Prostate

影响因子:2.5

doi:10.1002/pros.70135

Siech, Carolin; Brüggemann, Tonio; Le, Quynh Chi; Lauer, Benedikt; Humke, Clara; Preisser, Felix; Maurer, Tobias; Kriegmair, Maximilian; Graefen, Markus; Steuber, Thomas; Wenzel, Mike; Chun, Felix K H; Mandel, Philipp

Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy

一线ARPI治疗后，对未接受过紫杉烷类药物治疗的转移性去势抵抗性前列腺癌患者进行一线和二线治疗，采用镥-177 PSMA放射性配体疗法。

期刊:European Journal of Nuclear Medicine and Molecular Imaging

影响因子:7.6

doi:10.1007/s00259-025-07076-7

Wenzel, Mike; Hoeh, Benedikt; Siech, Carolin; Koll, Florestan; Humke, Clara; Groener, Daniel; Steuber, Thomas; Graefen, Markus; Maurer, Tobias; Banek, Severine; Chun, Felix K H; Mandel, Philipp

Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer

阿帕鲁胺治疗后前列腺特异性抗原最低值超低：同步性与异时性转移性激素敏感性前列腺癌的疗效

期刊:European Urology Open Science

影响因子:4.5

doi:10.1016/j.euros.2025.05.001

Wenzel, Mike; Steuber, Thomas; Siech, Carolin; Kriegmair, Maximilian; Hoeh, Benedikt; Tilki, Derya; Merseburger, Axel S; Chun, Felix K H; Mandel, Philipp

Patient-Reported Outcome Measures and Decision Regret After Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following Radiotherapy or Focal Therapy

接受放射治疗或局部治疗后复发性前列腺癌患者行挽救性根治性前列腺切除术后的患者报告结局指标和决策后悔情况

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers17030396

Falkenbach, Fabian; Hagemann, Johanna; Ambrosini, Francesca; Karakiewicz, Pierre I; Tian, Zhe; Nagaraj, Yamini; Beyer, Burkhard; Mandel, Philipp; Preisser, Felix; Tilki, Derya; Maurer, Tobias; Budäus, Lars; Heinzer, Hans; Haese, Alexander; Steuber, Thomas; Salomon, Georg; Graefen, Markus

Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer

同源重组修复/乳腺癌 (BRCA) 基因改变对转移性前列腺癌真实世界生存率的影响

期刊:Bju International

影响因子:4.4

doi:10.1111/bju.16462

Wenzel, Mike; Hoeh, Benedikt; Koll, Florestan; Humke, Clara; Fassl, Anne; Reis, Henning; Wild, Peter; Steuber, Thomas; Graefen, Markus; Tilki, Derya; Traumann, Miriam; Banek, Severine; Chun, Felix K H; Mandel, Philipp

Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer

在真实世界中转移性去势抵抗性前列腺癌患者中，骨修饰剂的给药和癌症控制结果

期刊:JBMR Plus

影响因子:2.4

doi:10.1093/jbmrpl/ziae157

Wenzel, Mike; Hoeh, Benedikt; Humke, Clara; Welte, Maria; Cano Garcia, Cristina; Siech, Carolin; Saad, Fred; Karakiewcz, Pierre I; Tilki, Derya; Steuber, Thomas; Graefen, Markus; Traumann, Miriam; Chun, Felix K H; Mandel, Philipp

Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancer

机器人辅助手术与开放式手术在复发性前列腺癌PSMA放射引导手术中的比较分析

期刊:European Journal of Nuclear Medicine and Molecular Imaging

影响因子:7.6

doi:10.1007/s00259-023-06460-5

Ambrosini, Francesca; Falkenbach, Fabian; Budäus, Lars; Steuber, Thomas; Graefen, Markus; Koehler, Daniel; Knipper, Sophie; Maurer, Tobias

Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancer

淋巴结分期在中危前列腺癌诊断中的准确性和预后

Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort

接受阿帕鲁胺治疗的转移性激素敏感性前列腺癌且骨转移灶≥10个的患者的癌症控制结果：一项真实世界队列研究

Influence of concomitant distant lymph node metastases in metastatic hormone-sensitive prostate cancer patients with bone metastases

伴随远处淋巴结转移对骨转移性激素敏感性前列腺癌患者的影响

External Validation of the Martini-Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High-Risk Prostate Cancer After Radical Prostatectomy

根据欧洲泌尿外科协会（EAU）指南，对接受根治性前列腺切除术的高危前列腺癌患者进行Martini-Klinik列线图预测辅助放射治疗适应症的外部验证

Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy

一线ARPI治疗后，对未接受过紫杉烷类药物治疗的转移性去势抵抗性前列腺癌患者进行一线和二线治疗，采用镥-177 PSMA放射性配体疗法。

Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer

阿帕鲁胺治疗后前列腺特异性抗原最低值超低：同步性与异时性转移性激素敏感性前列腺癌的疗效

Patient-Reported Outcome Measures and Decision Regret After Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following Radiotherapy or Focal Therapy

接受放射治疗或局部治疗后复发性前列腺癌患者行挽救性根治性前列腺切除术后的患者报告结局指标和决策后悔情况

Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer

同源重组修复/乳腺癌 (BRCA) 基因改变对转移性前列腺癌真实世界生存率的影响

Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer

在真实世界中转移性去势抵抗性前列腺癌患者中，骨修饰剂的给药和癌症控制结果

Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancer

机器人辅助手术与开放式手术在复发性前列腺癌PSMA放射引导手术中的比较分析